浦涧，教授，主任医师，肝胆外科主任，广西肝胆疾病临床研究中心副主任，硕士研究生导师。美国国立纽约大学西奈山医学中心留学归国高级学者，右江民族医学院附院普通外科学科带头人。

现兼任百色医学会普通外科专业主任委员、广西医学会普通外科分会副主任委员（副主委）、广西抗癌协会肝癌专业组副主委、广西中西医结合普通外科学会副主委、广西医师协会普通外科医师分会副主委、广西医师协会微创外科医师分会副主委、广西医师协会腔镜外科医师分会副主委、广西医师协会肝癌专业组副主委、广西肿瘤学会常委。

对肝、胆、胰、脾、胃肠、乳腺、甲状腺等普通外科疾病有深入研究，常规开展各种普通外科手术，精通腹腔镜微创手术，多项技术填补桂西地区空白。主持多项省部级课题，已发表医学专著1部，论文90余篇，其中SCI 17篇。是百色市优秀高层次人才，曾获自治区卫生系统优秀再教育工作者、右江民族医学院优秀研究生导师、十佳教师、优秀教师，右江民族医学院附属医院十佳医师等称号。

近3年发表的研究论文：

[1]Silencing hsa_circ_0000092 downregulates expression of HN1 and inhibits hepatocellular carcinoma progression by microRNA-338-3p. Journal of Cellular and Molecular Medicine, 2020. doi: 10.1111/jcmm.15010. （SCI, IF=4.658)

[2]CircNT5E promotes tumorigenesis in liver cancer by regulating miR-422a/KLK4/HGF/c-Met axis2. Artificial Cells Nanomedicine and Biotechnology，2020. (SCI, IF=4.462)

[3]miR-654-5p targets HAX-1 to regulate the malignancy behaviors of colorectal cancer cells. biomed research international，10 February 2020， Volume 2020, Article ID 4914707, 6 pages. https://doi.org/10.1155/2020/4914707 (SCI, IF=2.197)

[4]LncRNA OIP5-AS1 interacts with miR-363-3p to contribute to hepatocellular carcinoma progression through up-regulation of SOX4.  Gene Therapy,  2020, doi: 10.1038/s41434-020-0123-2. （SCI, IF=3.71)

[5] lncRNA MAGI2-AS3 Prevents the Development of HCC via Recruiting KDM1A and Promoting H3K4me2 Demethylation of the RACGAP1 Promoter. Mol Ther Nucleic Acids. 2019 Aug 28;18:351-362. doi: 10.1016/j.omtn.2019.08.020. (SCI, IF:5.919)

[6] miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway. Biomedicine & Pharmacotherapy，Volume 120, December 2019, 109551.  doi.org/10.1016/j.biopha.2019.109551(SCI, IF:3.78)

[7]Long noncoding RNA SNHG14 facilitates hepatocellular carcinoma progr-ession through regulating miR-4673/SOCS1. Am J Transl Res. 2019 Sep 15;11(9):5897-5904. eCollection 2019. (SCI, IF:3.546)

[8] Long noncoding RNA HAGLROS promotes cell proliferation, inhibits apoptosis and enhances autophagy via regulating miR-5095/ATG12 axis in hepatocellular carcinoma cells. International Immunopharmacology. 2019, apr,24. PMID: 31082725 .DOI: 10.1016/j.intimp.2019.04.049.(SCI, IF:3.118)

[9] MiR-584-5p regulates hepatocellular carcinoma cell migration and invasion through targeting KCNE2. Molecular Genetics & Genomic Medicine, 2019. https://orcid.org/0002-9310-0195.(SCI, IF:2.698)

[10] MiR-632 functions as oncogene in hepatocellular carcinoma via targeting MYCT1. Human Gene Therapy Clinical Development, Monday, 8 May 2019， https://doi.org/10.1089/humc.2019.040. (SCI，IF:2.778)

[11] Insight into the molecular mechanism of LINC00152/miR-215/CDK13 axis in hepatocellular carcinoma progression. Journal of Cellular Biochemistry, 2019；DOI: 10.1002/jcb.29197. (SCI, IF: 2.959)

[12] MicroRNA-200c expression is decreased in hepatocellular carcinoma and associated with poor prognosis. Clinics and Research in Hepatology and Gastroenterology, 2019 Apr 5. pii: S2210-7401(19)30061-0. doi: 10.1016/j.clinre.2019.03.005. (SCI, IF:1.461)

[13] LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway. Journal of Cellular Physiology, 2018.doi:10.1002/jcp.27449. (SCI, IF:3.96)

[14] The underlying pathophysiology association between the type 2-Diabetic and hepatocellular carcinnoma. Journal of Cellular Physiology, 2018. doi:10.1002/jcp.27919. (SCI, IF:3.96)

[15] Four lncRNAs as potential prognostic biomarkers for hepatocellular carcinoma in Journal of Cellular Physiology . Journal of Cellular Physiology,2018.，doi:10.1002/jcp.27530. (SCI, IF:3.96)

[16] DANCR Contributed To Hepatocellular Carcinoma Malignancy Via Sponging miR-216a-5p And Modulating KLF12. Journal of Cellular Physiology, 2018.，doi:10.1002/jcp.27625. (SCI, IF:3.96)

[17]蛋白激B通过调控低氧诱导因子-1表达干预人肝细胞癌系SMMC-7721增殖.医学基础与临床，2019，39（3）:360-364。(核心期刊，IF=0.49)

[18]标准化残肝比例预测ALPPS术后肝功能不全的临床价值;肝胆胰外科杂志，2018，30(1):5-9。（独家）（核心期刊，F=0.967）

[19]90°左侧卧位腹直肌旁视孔腹腔镜下非解剖性肝右后叶切除术的临床研究。肝胆胰外科杂志，2018，30（4）：265-270。（独家）（核心期刊，F=0.967）

[20]沉默低氧诱导因子与蛋白激酶B基因联合干预人肝癌细胞株SMMC-7721增殖。中华实验外科杂志，2018，35（12）：2340。（中华系列核心，F=0.98）

[21]Association between the ERCC2 Asp312Asn polymorphism and risk of cancer. Oncotarget, 2017, 8(29):48488-48506.doi:10:18632/Oncotarget 17290. (SCI， IF=5.008)

[22]左卡尼汀通过激活Nrf2/HO-1途径减轻大鼠肝脏热缺血再灌注损伤[J].中华肝胆外科杂志,2017;23(2):121-125。(中华系列核心，IF=1.85)

[23]热缺血再灌注损伤早期大鼠肝脏基因表达谱的实验研究[J].右江医学,2017,45（1）:25-6。（IF=0.637）

[24]左侧卧位腹直肌旁视孔腹腔镜下非解剖性肝右后叶切除体会（附15例报告）[J].中华肝胆外科杂志,2017;23(6)。(中华系列核心，IF=1.85)